Sample preparation
Brain samples were minced and suspended in Media I buffer (10 
Measurement of 3-nitrotyrosine
Levels of total 3-NT were determined immunochemically [3] . Samples (5 l 
) were incubated with 5 l Laemmli buffer without reducing agents (0.125 M Tris base pH 6.8, 4% (v/v) sodium dodecyl sulfate (SDS) and 20% (v/v) glycerol). The resulting sample (250 ng) was loaded per well in the slot blot apparatus. Samples were loaded onto a nitrocellulose membrane under vacuum pressure. The membrane was blocked with 3% (w/v) bovine serum albumin (BSA) in wash blot for 2 hrs and incubated with a 1:2000 dilution of anti-3-NT polyclonal antibody (Sigma Aldrich
,
In-gel trypsin digestion

Results
The total level of nitrated proteins in the IPL of EAD patients yielded a significant 18% increase compared with age-matched controls (Fig. 1) [19, [30] [31] [32] [33] [34] [35] 
, the activities of a subset of identified nitrated proteins for IPL of EAD subjects were determined. ATP synthase activity was measured in EAD IPL and was 30% lower in EAD IPL compared with agematched controls (Fig. 4). ATP synthase also is lower in brains from subjects with MCI, and these results are consistent with the notion of loss of enzymatic activity of oxidatively modified proteins [30, 32]. Glutamate dehydrogenase activity also was reduced by 40% in EAD IPL compared with age-matched controls (Fig. 5). Iwatsuji et al. reported lowered GDH activity in lymphocytes from
AD patients compared with control [36] . 
Discussion
Several proteins were found to be significantly nitrated in EAD IPL. They are involved in antioxidant defence, energy metabolism, lipid
asymmetry, and ATP production. This discussion has been written by categorizing these oxidatively modified proteins by function. In this manner, it is easier to envisage how oxidative modification can greatly impair protein function and how this can correlate with AD pathology.
Antioxidant defence
Peroxiredoxins are peroxidases that serve in an antioxidant capacity by reducing hydrogen peroxide. There are six forms of peroxiredoxin. Prx 1 -2, -3, -4 and -5 use thioredoxin as an electron donor, whereas
Prx-6 uses glutathione. Prx2 (or thio-specific antioxidant), only expressed in neurons, blocks apoptosis by preventing the opening of the mitochondrial permeability pore [37] and thereby promotes neuronal cell survival [38, 39] . Overexpression of Prx2 in cell lines ameliorates apoptotic effects induced by oxidants [40] . Prx2, which can be neuroprotective, is increased in PD [41] as well as AD and Down syndrome [42, 43] . Prx2 also reduces peroxynitrite to detoxify RNS [44] . Loss of protein function hampers peroxidase activity and would be predicted to yield an increase in cytotoxic RNS. [45, 46] . In particular, the family of peroxiredoxins, coupled to thiol homeostasis, could exert a neuroprotective role in age-related neurodegenerative disorders such as AD, and may be a promising, novel therapeutic target for this and other age-related neurodegenerative disorders.
We hypothesize that these findings have relevance to the emerging concepts of redox regulation of cellular stress response (vitagenes) in response to oxidative and nitrosative stress
Metabolic enzymes
As noted above, TPI is a glycolytic enzyme that catalyses production of glyceraldehyde-3-phosphate (G3P), which is required to continue glycolysis to produce ATP. In AD brain, TPI is oxidatively modified [2, 3] MCI [47] and late AD [2, 48] . Altered energy metabolism is a common motif in neurodegenerative diseases as ␣-enolase also is oxidatively modified in MCI [47] , late AD [31, 49] , PD [50] , Huntington's disease [33] and amyotrophic lateral sclerosis [51] . Notably, ␣-enolase is the only nitrated protein to overlap MCI, EAD and late AD [2, 31, 47] . This observation supports the notion that changes in energy metabolism need to be investigated further to gain more knowledge about AD pathogenesis and potentially offer targets for therapeutic intervention of AD.
PGM1 catalyses the interconversion of 3-phosphoglycerate to 2-phosphoglycerate, leading to a second equivalent of ATP produced in glycolysis. Enzyme activity is decreased in AD [52] , which could result in protein dysfunction and increased glycolytic intermediates, reduced pyruvate production and decreased ATP production. PGM1 is oxidatively modified in rat brain treated with A␤ and AD hippocampus. In the gracile axonal dystrophy mouse brain in which A␤ is deposited, PGM1 is significantly increased, which contributes to the notion of reduced energy metabolism in neurodegenerative diseases [53, 54] .
ALDO1 cleaves fructose1,6 -bisphosphate into dihydroxyacetone phosphate (DHAP) and G3P in glycolysis. Levels of ALDO1 are significantly decreased in AD hippocampus [4] and this enzyme is oxidatively modified in the olfactory bulb of aged mice [55] . Getchell et al. reported increased 3-NT immunoreactivity in olfactory bulbs of late AD patients compared with agematched controls [56] . A diminished sense of smell (olfaction) is observed in some AD patients, as in the case of aging and several age-related neurodegenerative diseases [57, 58] . ALDO1 and TPI deficiencies are associated with hemolytic anaemia resulting in mitochondrial myopathy [59] [60] [61] . Enzyme activity is reduced and impairment can cause increased levels of fructose 1,6-bisphosphate, inhibition of complete glycolysis, and ATP depletion. [2] and modified by the lipid peroxidation product, HNE, in synaptosomes treated with A␤ [62] . Loss of PEBP may affect lipid asymmetry as loss of activity is observed in AD [63] . [68] and activity are decreased in AD [69] [70] [71] [72] . H ϩ transporting two-sector ATPase is oxidized in synaptosomes treated with the peptide A␤ [62] . Reduction in enzyme activity in brain of subjects with EAD (Fig. 4) , coupled with changes in the mitochondrial complex, can lead to electron leakage and reactive oxygen species production, potentiating oxidative stress in AD via mitochondrial dysfunction [73] [74] [75] . [2, 3, 31, 35, 47] . Aldolase, phosphoglycerate mutase 1, neuropolypeptide h3 and TPI are oxidatively modified in EAD and late AD brain [2, 31, 35, 47] . Our data suggest that protein nitration of these specific brain proteins could be a mechanism to trigger the further conversion of EAD to more advanced AD. A Venn diagram (Fig. 6) 
Lipid asymmetry
ATP production
Glutamate dehydrogenase (GDH), located in the mitochondrial matrix, catalyses the reversible deamination of glutamate to
